Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Ordinary Shares, $0.00001 Par Value
-
Shares outstanding
-
494M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
7.01K
-
Shares change
-
-6.97K
-
Total reported value, excl. options
-
$230K
-
Value change
-
-$86K
-
Number of buys
-
2
-
Number of sells
-
-3
-
Price
-
$32.06
Significant Holders of Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC) as of Q4 2021
5 filings reported holding RGC - Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value as of Q4 2021.
Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.01K shares
of 494M outstanding shares and own 0% of the company stock.
Largest 5 shareholders include GEODE CAPITAL MANAGEMENT, LLC (6.82K shares), UBS Group AG (192 shares), MORGAN STANLEY (0 shares), Tower Research Capital LLC (TRC) (0 shares), and Schonfeld Strategic Advisors LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.